On March 14, 2016, Greatbatch Inc. completed the previously announced spin-off of Nuvectra Corporation. On March 14, 2016 prior to the Spin-off and in connection with the conversion of the company into a Delaware corporation, each member of the Board of Managers of the company resigned from all positions with the company, and Greatbatch, as the sole stockholder of the company, appointed eight directors to serve as the Nuvectra Board of Directors. The newly appointed directors of the Nuvectra are (i) Dr. Joseph Miller, Jr., who stepped down from the Greatbatch Board of Directors and is serving as Chairman of the Nuvectra Board, (ii) Scott F. Drees the Company's President and Chief Executive Officer, (iii) Anthony P. Bihl III, who stepped down from the Greatbatch Board of Directors, (iv) Kenneth G. Hawari; (v) David D. Johnson, (vi) Dr. Fred B. Parks, PhD, (vii) Jon T. Tremmel, and (viii) Thomas E. Zelibor.

The Nuvectra's Board of Directors is constituted into three classes, as follows: Class I: David Johnson, Jon Tremmel and Fred Parks serve in the first class of directors whose terms expire at the first annual meeting of Nuvectra stockholders following the Spin-off, which the Company expects to hold in 2017; Class II: Kenneth Hawari, Thomas Zelibor and Anthony Bihl serve in the second class of directors whose terms expire at the second annual meeting of Nuvectra stockholders following the Spin-off, which the Company expects to hold in 2018; and Class III: Joseph Miller and Scott Drees serve in the third class of directors whose terms expire at the third annual meeting of Nuvectra stockholders following the Spin-off, which the company expects to hold in 2019. Dr. Joseph A. Miller, Jr. will serve as Chairman of the Board of Nuvectra. He currently serves as a director for Greatbatch and will step down from Greatbatch's board of directors shortly before the completion of the spin-off.

Dr. Miller also currently serves as a director of Lightwave Logic Inc., or Lightwave Logic, and previously served as a director of Dow Corning Corporation. Anthony P. Bihl III will serve as a director of Nuvectra. He currently serves as a director for Greatbatch and will step down from Greatbatch's board of directors shortly before the completion of the spin-off.

Mr. Bihl has been Chief Executive Officer and a member of the Board of Managers of Bioventus, LLC, a company that develops, manufactures and sells products that promote active orthopaedic healing, since December 2013. Kenneth G. Hawari will serve as a director of Nuvectra. Since 2007, Mr. Hawari has worked as an attorney and business consultant in private practice.

David D. Johnson will serve as a director of Nuvectra. From May 2005 until his retirement on February 1, 2016, Mr. Johnson served as the Executive Vice President, Treasurer & Chief Financial Officer of Molex, LLC (previously Molex Incorporated), which is a manufacturer of electronic connectors and components. Mr. Johnson currently serves as a director, chairman of the audit committee, and member of the compensation committee of MTS Systems Corporation, which is a global supplier of test systems and industrial position sensors.

Dr. Fred B. Parks, PhD, will serve as a director of Nuvectra. Dr. Parks has been the Chief Executive Officer of Enovate Medical since July 2015. Prior to joining Enovate Medical, Dr. Parks served as Chief Executive Officer of NDS Surgical Imaging, LLC from August 2011 to 2013 and Chairman and Chief Executive Officer of Urologix Inc. from May 2003 to February 2008.

Jon T. Tremmel will serve as a director of Nuvectra. Until his retirement in 2007, Mr. Tremmel held several senior leadership positions with Medtronic plc, or Medtronic, including President of the Neurological Division from March 2003 to April 2007, President of the Physio-Control Division from May 2001 to March 2003 and President of the Tachyarrhythmia Management Division and President of the Interventional Vascular Division from 1992 to 2001. Thomas E. Zelibor will serve as a director of Nuvectra.

Since May 2012, Mr. Zelibor has been the Chief Executive Officer and Chairman of the Board of Lightwave Logic, a publicly traded company focused on utilizing thin film polymers for electro-optic devices employed in the telecom and datacom markets. Scott F. Drees will serve as President, Chief Executive Officer and as a director of Nuvectra. Prior to joining Nuvectra on a full time basis, Mr. Drees served as a consultant to Nuvectra and subsidiaries Algostim and PelviStim since August 2009.